Autopsy report · NCT01841931

Buprenorphine Treatment: A Safe Alternative for Opioid Dependent Pain Patients

“Principal Investigator is no longer at this site”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 6 months before it stopped.
• 4 participants enrolled.
• Results were posted on the registry 4 years 8 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Theresa Jacob, PhD, MPH

Sponsor type

University, hospital or other

Conditions

Opioid Use Disorder; Opioid Dependence; Chronic Pain

Interventions

Buprenorphine/Naloxone

Participants

4

Sites

1

Countries

United States

Trials that died the same way

• Feasibility of a Non-invasive, Trans-abdominal, Low Cost Fetal Oximetry Probe on Pregnant Human Subjects
  “Principal Investigator no longer at Site” (96% match in meaning)
• Identification and Characterization of Molecular Markers in Musculoskeletal Tumors
  “Principal Investigator has left the Institution” (82% match in meaning)
• Laser Therapy in the Treatment of Post Thoracotomy Pain; A Pilot Study
  “Principal Investigator left the institution” (79% match in meaning)
• Premavision Cohort Follow-up
  “Principal Investigator not available anymore (Sabbatical)” (79% match in meaning)
• Target Sign vs Palpation for Radial Arterial Line Placement
  “Principal Investigator retired” (78% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.